Table.
Cases of Pneumothorax after Bevacizumab-containing Chemotherapy.
| References | Age | BMI | Diagnosis | CTx | Onset | Imaging | Treatment | Outcome | Subsequent |
|---|---|---|---|---|---|---|---|---|---|
| Sex | (kg/m2) | use of BV | |||||||
| 11) | 45 | N.D. | Colon cancer | BV | 21days | Xp: Right-side | Chest tube | Recovery | N.D. |
| M | Lung meta. | FOLFOXIRI | (2nd cycle) | pneumothorax | insertion | in 5days | |||
| 12) | 70 | 22.0 | Pulmonary | BV | 7days | Xp, CT: Left-side | Chest tube | Recovery | - |
| F | cancer | CBDCA, PTX | (1st cycle) | pneumothorax | insertion | in 45days | |||
| CT: Hollowing | Pleurodesis | ||||||||
| tumor inside | |||||||||
| 13) | 23 | N.D. | Fibrosarcoma | BV | 55days | Xp: Bilateral | Chest tube | Recovery | + |
| M | DTX, CDDP | (3rd cycle) | pneumothorax | insertion | in 3days | ||||
| 14) | 62 | N.D. | Breast cancer | BV | 8 months | Xp, CT: Left-side | Chest tube | Recovery | - |
| F | Lung meta. | PTX | pneumothorax | insertion | in 6weeks | ||||
| CT: Hollowing | Pleurodesis | ||||||||
| tumor inside | |||||||||
| Our case | 57 | 22.1 | Colon cancer | BV | 6months | Xp, CT: Left-side | Chest tube | No recovery | - |
| M | Lung meta. | FOLFIRI | (13th cycle) | pneumothorax | insertion | in 3weeks | |||
| CT: Consolidation | Pleurodesis | ||||||||
| → Bulla |
BMI: Body Mass Index, CTx: Chemotherapy, BV: Bevacizumab, N.D.: Not Detected, meta.: metastasis, FOLFOXIRI: 5-Fluorouracil, Oxaliplatin, Irinotecan, CBDCA: Carboplatin, DTX: Docetaxel, CDDP: Cisplatin, PTX: Paclitaxel, FOLFIRI: 5-Fluorouracil, L-Leucovorin, Irinotecan